Founded at the Abramson Cancer Center at the University of Pennsylvania

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

The New England Journal of Medicine │ 2017

Mark Robson; Seock-Ah Im; Binghe Xu; Susan M. Domchek; Norikazu Masuda; Suzette Delaloge; Wei Li; Nadine Tung; Anne Armstring; Wenting Wu; Carsten Goessl; Sarah Runswick; Pierfranco Conte